125 related articles for article (PubMed ID: 8022849)
21. Studies on 15-hydroxyprostaglandin dehydrogenase with various prostaglandin analogues.
Ohno H; Morikawa Y; Hirata F
J Biochem; 1978 Dec; 84(6):1485-94. PubMed ID: 216666
[TBL] [Abstract][Full Text] [Related]
22. Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension.
Camras CB; Schumer RA; Marsk A; Lustgarten JS; Serle JB; Stjernschantz J; Bito LZ; Podos SM
Arch Ophthalmol; 1992 Dec; 110(12):1733-8. PubMed ID: 1463414
[TBL] [Abstract][Full Text] [Related]
23. Phenyl-substituted prostaglandins: potent and selective antiglaucoma agents.
Resul B; Stjernschantz J; No K; Liljebris C; Selén G; Astin M; Karlsson M; Bito LZ
J Med Chem; 1993 Jan; 36(2):243-8. PubMed ID: 8423596
[TBL] [Abstract][Full Text] [Related]
24. Studies on the ocular hypotensive effects of prostaglandin F2 alpha ester prodrugs and receptor selective prostaglandin analogs.
Woodward DF; Chan MF; Burke JA; Cheng-Bennett A; Chen G; Fairbairn CE; Gac T; Garst ME; Gluchowski C; Kaplan LJ
J Ocul Pharmacol; 1994; 10(1):177-93. PubMed ID: 8207325
[TBL] [Abstract][Full Text] [Related]
25. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function.
Toris CB; Camras CB; Yablonski ME; Brubaker RF
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S69-75. PubMed ID: 9154279
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antifertility activity of omega-chain phenyl- and 16-phenoxy-analogues of (+/-)-11-deoxyprostaglandin F1 alpha.
Broughton BJ; Caton MP; Coffee EC; Hambling DJ; Palfreyman MN; Withnall MT; Wooldridge KR
Prostaglandins; 1980 Apr; 19(4):559-75. PubMed ID: 7384556
[TBL] [Abstract][Full Text] [Related]
27. Organ selective conversion of prostaglandin D2 to 9 alpha, 11 beta-prostaglandin F2 and its subsequent metabolism in rat, rabbit and guinea pig.
Hoult JR; Bacon KB; Osborne DJ; Robinson C
Biochem Pharmacol; 1988 Oct; 37(19):3591-9. PubMed ID: 3178873
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of latanoprost in the cynomolgus monkey. 2nd communication: repeated topical administration on the eye.
Sjöquist B; Uhlin A; Byding P; Stjernschantz J
Arzneimittelforschung; 1999 Mar; 49(3):234-9. PubMed ID: 10219467
[TBL] [Abstract][Full Text] [Related]
29. Maintained intraocular pressure reduction with once-a-day application of a new prostaglandin F2 alpha analogue (PhXA41). An in-hospital, placebo-controlled study.
Rácz P; Ruzsonyi MR; Nagy ZT; Bito LZ
Arch Ophthalmol; 1993 May; 111(5):657-61. PubMed ID: 8489449
[TBL] [Abstract][Full Text] [Related]
30. In vitro corneal permeation of unoprostone isopropyl (UI) and its metabolism in the isolated pig eye.
Babiole M; Wilhelm F; Schoch C
J Ocul Pharmacol Ther; 2001 Apr; 17(2):159-72. PubMed ID: 11324983
[TBL] [Abstract][Full Text] [Related]
31. Antinidatory effect of luteal phase administration of mifepristone (RU486) is associated with changes in endometrial prostaglandins during the implantation window.
Nayak NR; Sengupta J; Ghosh D
Contraception; 1998 Aug; 58(2):111-7. PubMed ID: 9773266
[TBL] [Abstract][Full Text] [Related]
32. Effects of PhXA41, a prostaglandin analogue, and PGF2 alpha on the corneal and intraretinal d.c. electroretinogram (ERG) of the albino rabbit eye.
Bragadóttir R; Jarkman S
Curr Eye Res; 1995 Dec; 14(12):1073-80. PubMed ID: 8974836
[TBL] [Abstract][Full Text] [Related]
33. Novel prostaglandin dehydrogenase in rat skin.
Fincham N; Camp R
Biochem J; 1983 Apr; 212(1):129-34. PubMed ID: 6575778
[TBL] [Abstract][Full Text] [Related]
34. The effects of prostaglandins on the blood-ocular barrier.
Kosaka T; Mishima HK; Kiuchi Y; Kataoka K
Jpn J Ophthalmol; 1995; 39(4):368-76. PubMed ID: 8926644
[TBL] [Abstract][Full Text] [Related]
35. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
[TBL] [Abstract][Full Text] [Related]
36. Effect of latanoprost on regional blood flow and capillary permeability in the monkey eye.
Stjernschantz J; Selén G; Astin M; Karlsson M; Resul B
Arch Ophthalmol; 1999 Oct; 117(10):1363-7. PubMed ID: 10532445
[TBL] [Abstract][Full Text] [Related]
37. The hydrolysis of the prostaglandin analog prodrug bimatoprost to 17-phenyl-trinor PGF2alpha by human and rabbit ocular tissue.
Hellberg MR; Ke TL; Haggard K; Klimko PG; Dean TR; Graff G
J Ocul Pharmacol Ther; 2003 Apr; 19(2):97-103. PubMed ID: 12804054
[TBL] [Abstract][Full Text] [Related]
38. Eicosanoids as a new class of ocular hypotensive agents. 3. Prostaglandin A2-1-isopropyl ester is the most potent reported hypotensive agent on feline eyes.
Bito LZ; Miranda OC; Tendler MR; Resul B
Exp Eye Res; 1990 Apr; 50(4):419-28. PubMed ID: 2338124
[TBL] [Abstract][Full Text] [Related]
39. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
Bhattacherjee P; Williams BS; Paterson CA
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
[TBL] [Abstract][Full Text] [Related]
40. Ocular and systemic pharmacokinetics of latanoprost in humans.
Sjöquist B; Stjernschantz J
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S6-12. PubMed ID: 12204697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
